Published in Women's Health Weekly, September 16th, 2004
C.E. Wood and associates at Wake Forest University "evaluated the long-term effects of soy isoflavones on intermediate markers of cancer risk in the normal postmenopausal monkey breast and uterus."
"Ovariectomized female cynomolgus monkeys were randomized to receive one of three diets for 36 months: 1) isoflavone-depleted soy protein isolate (SPI-) (n=57); 2) soy protein isolate with the equivalent of 129 mg/d isoflavones (SPI+) (n=60); or 3) isoflavone-depleted soy protein isolate with conjugated equine...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.